The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome.
Kristina NoringMattias CarlstenKristina SonneviBjörn Engelbrekt WahlinPublished in: BMC cancer (2021)
We conclude that the improved outcome reflects better, PET/CT-informed, identification of patients who should proceed to ASCT. The excellent survival of patients in PET/CT-CR indicates that ASCT should remain part of standard therapy for lymphoma.
Keyphrases
- pet ct
- positron emission tomography
- stem cell transplantation
- end stage renal disease
- computed tomography
- diffuse large b cell lymphoma
- high dose
- ejection fraction
- chronic kidney disease
- newly diagnosed
- rheumatoid arthritis
- peritoneal dialysis
- bone marrow
- disease activity
- low dose
- systemic lupus erythematosus
- free survival